Oracle's AI data‑centre expansion forces $45–50B financing, restructuring and credit scrutiny

AI data‑centre buildout forces sweeping financing and restructuring considerations

Oracle is undertaking an aggressive expansion of AI data‑centre capacity that is forcing the company into large‑scale financing and restructuring decisions, prompting renewed scrutiny from credit markets and analysts. The company is planning to raise roughly $45 billion to $50 billion this year to fund cloud infrastructure and GPU as a Service (GPUaaS) offerings, a push that Morgan Stanley says will materially pressure earnings and likely require significant additional borrowing. Credit default swaps on Oracle widen to levels not seen since the 2008 crisis amid the funding drive, reflecting investor concern over the pace and scale of the investment.

Pressure from lenders and rating observers is prompting Oracle to weigh operational and asset moves to shore up cash flow. TD Cowen flags internal plans that could include cutting 20,000 to 30,000 jobs and selling non‑core assets, a package that analysts estimate could free $8 billion to $10 billion. Barclays warns the company may face severe liquidity strain and projects a scenario in which Oracle exhausts cash reserves by the end of 2026 without decisive action. At the same time, the company is considering strategic divestitures such as the sale of Cerner, the healthcare software unit acquired in 2022 for $28.3 billion, as executives seek to rebalance the balance sheet while continuing capital‑intensive AI deployments.

Market and analyst commentary frames the financing move as both necessary for competitiveness in cloud AI and risky for Oracle’s credit profile. Morgan Stanley recommends hedging credit exposure by buying five‑year CDS protection, forecasting spreads could reach about 200 basis points, while rating agencies remain attentive to how much new debt the expansion will require. Fitch affirms a BBB rating even as markets debate the sustainability of the capital plan, leaving Oracle to juggle growth ambitions with mounting scrutiny from credit investors and regulators.

Allegations of insufficient disclosure spur class action

A New York state class action firm alleges Oracle’s shelf registration and supplements omit material facts about its need for additional debt to build AI infrastructure, saying the disclosures mislead purchasers of senior notes — an action that could add legal risk and potential liabilities if the case progresses.

Healthcare AI pilot points to product demand amid pressures

Separately, Oracle Health signs a pilot with Lumeo Regional Health Information System in Ontario to deploy a voice‑enabled Clinical AI Agent into a shared EHR, illustrating demand for Oracle’s AI clinician tools even as the parent company navigates financing and restructuring challenges.